From the Division of Molecular Imaging and Theranostics, Department of Nuclear Medicine, University Hospital, Paracelsus Medical University, Salzburg, Austria.

Received for publication August 15, 2023; revision accepted December 29, 2023.

Conflicts of interest and sources of funding: none declared.

Correspondence to: Mohsen Beheshti, MD, FEBNM, FASNC, Division of Molecular Imaging and Theranostics, Department of Nuclear Medicine, University Hospital Salzburg, Paracelsus Medical University Salzburg, Muellner Hauptstrasse 48, 5020-Salzburg, Austria. E-mail: [email protected].